Position in KOD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,629,420
-$3,890,419 QoQ
Shares Held
305,074
-45.0% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in KOD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. KOD ranks #52 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in KOD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,629,420 | 305,074 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,519,839 | 555,073 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $1,639,929 | 100,179 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $286,708 | 76,866 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $227,586 | 80,992 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,164,148 | 519,010 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $209,777 | 80,375 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $177,347 | 75,467 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,709,966 | 705,317 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $240,751 | 79,195 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $141,686 | 78,715 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $475,216 | 68,872 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $405,857 | 65,461 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $171,480 | 23,950 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $186,161 | 24,052 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $189,792 | 24,842 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $193,956 | 25,124 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $47,659,669 | 562,157 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,535,258 | 568,194 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $35,666,616 | 383,512 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $43,144,666 | 380,498 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $64,072,884 | 436,137 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $1,963,526 | 36,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,864,210 | 39,082 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||